Active, Not Recruiting
Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
NCT04127110
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Institut Jules Bordet-Hopital Universitaire ULB Brussels, Belgium
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- Universitair Ziekenhuis Antwerpen Edegem, Belgium
- CHU-UCL Namur - CHU Mont Godinne - UCL Namur Yvoir, Belgium